国产真实乱对白精彩_CHINA四川少妇VIDEOS_久久久久久午夜成人影院_国产高清在线男人的天堂

Chairman's SpeechCorporate CultureCorporate QualificationsDevelopment HistoryOrganizational ChartCirculation Enhancement Pill   氣血雙補丸Vigour and Vitality Supplement Pill   補腎填精丸Kidney Invigoration Pill   金匱腎氣丸Menstrual Discomfort Relief Pill   加味逍遙丸Six-Ingredient Rehmannia Pill   六味地黃丸Cinnabar Nerve-calming Pill   朱砂安神丸Anemarrhena, Phellodendron and Rehmannia Pill知柏地黃丸Bazhen Yimu Pill   八母益珍丸Arborvitae Seed Heart Nourishing Pill   柏子養心丸Spleen Invigorating and Qi Replenishing Pill 補中益氣丸Eight-ingredient Rehmannia Pill   麥味地黃丸Lycium, Chrysanthemum and Rehmannia Pill   杞菊地黃丸Tianwang Heartreplenishing Pill   天王補心丸Relief Pill   逍遙丸Six-Ingredient Rehmannia Pill 2   六味地黃丸2Anemarrhena, Phellodendron and Rehmannia Pil知柏地黃丸2QI-DEFICIENCY AND BLOOD-STASIS CONDITIONHeart Wellness Capsule   心安膠囊Cardiotonic Enhancement Capsule   山玫膠囊CARDIO-CEREBROVASCULAR CONDITIONLiver-dispersing and Stomachregulating Pill  舒肝和胃丸Liver Detox Tablet   護肝片Daochi Pill   導赤丸Chinese Goldthread Rhizome Supernatant Pill  黃連上清丸Calculus Bovis Detoxification Pill   牛黃解毒丸Calculus Bovis Supernatant Pill   牛黃上清丸Liver-dispersing and Stomachregulating Pill 舒肝和胃丸2DIGESTIVE AND GASTROINTESTINAL CONDITIONCirculation Enhancement Pill   氣血雙補丸Bazhen Yimu Pill   八珍益母丸Relief Pill   逍遙丸Nutgrass Galingale Rhizome Pill   香附丸GYNAECOLOGICAL CONDITIONAdditional Ingredient Huoxiang ZhengQi Pill加味藿香正氣丸Fever-removing and Detoxification Pill   清瘟解毒丸Tangerine Pill   橘紅丸Lung-ventilating and Lungregulating Pill   通宣理肺丸Yin-nourishing and Lung-cooling Pill   養陰清肺丸Nutgrass Galingale Rhizome Pill   香附丸SYMPTOMS OF COVID-19 SIMILAR ILLNESSSmall Meridianactivating Pill   小活絡丸Dizzinessrelieving Pill   清眩丸OTHERSCompany NewsPolicies and RegulationsGovernance StructureBoard of directorsCorporate GovernanceAnnouncements and NoticeListing documentsAnnouncement and circularReturn of EquityFinancial reportsStock informationInvestor relations liaison
Modern Chinese Medicine Group Co.,Ltd.

2016年度藥品檢查報告

Issuing time:2020-02-27 00:00Source:國家食品藥品監督管理總局

(II) The enterprises unqualified in casual inspections in 2015

A total of 11 critical deficiencies, 27 major deficiencies and 84 general deficiencies were identified in the inspections on 11 enterprises.


  Main findings were as follows:

1. Production process was inconsistent with registered process

2. Problems in data integrity

3. Problems in process validation

(III) Double random inspection

A total of 5 critical deficiencies, 24 major deficiencies and 123 general deficiencies were identified.


  Main findings were as follows:

1. Record falsification

2. Potential hazards in product quality and safety

3. Problems in data integrity

4. Problems in process validation

5. Non-standardized material management with the risks in pollution, confusion and error.

6. Incomplete cleaning, which cannot effectively prevent contamination and cross-contamination.

(IV) Vaccine manufacturers

38 major deficiencies and 383 general deficiencies were identified.


  Main findings:

1. Equipment. There was a too long stagnant water section between the stainless steel pipe valve through which water for injection preparation system enters into injection water storage tank and water generator; Individual device had rust.

2. Materials and Products. The quantity of the destructed items was not recorded in the destruction records of the non-conforming finished products; the enterprise failed to establish the background information of whole-genome sequence of main bacterial and viral seeds for production.

3. Documentation Management. Individual document was not specifically specified and was poor in its operability. The content specified in the document was inconsistent with the actual situation; individual record had incomplete content; the batch production records were unreasonably designed and were not timely filled in actual operation.

4. Quality Control and Quality Assurance

(1) Quality management of laboratories: the enterprise failed to request necessary test data and maps from the institutions conducting entrusted test; some material was subject to infrared test after sample mixing.

(2) the Deviation handling: The training and implementation of the documents related to deviation handling was not conducted; the enterprise failed to timely initiate the investigation for individual deviation; the reason analysis and corrective and preventive measures for a few deviations were not in place, and there was in adequate assessment on the potential impact of the deviations on the quality of products.

(3) Change control: The enterprise failed to handle the changes in accordance with change process and submit supplementary application for registration. There was no or inadequate assessment on some changes;

(4) Supplier management: There was incomplete auditing content for the suppliers of some materials, and the enterprise failed to determine the auditing content for suppliers based on the impact of the material on product quality.

(5) Product quality review: The enterprise failed to conduct annual quality review by varieties.

5. Computer System. The enterprise has developed document system for computer system management, but did not conduct classification management in accordance with the system, and did not take effective measures to reduce risks for the situation that existing conditions failed to comply with the document; there was no permission setting for the login screen of HPLC testing equipment in quality verification laboratory, and no measures to prevent the login by the unauthorized person.

(V) Blood product manufacturers

In the inspections on 25 enterprises, 13 major deficiencies and 241 general deficiencies were identified, and no critical deficiency was identified.

Prev
...
6 7 8 9 10
...
Next
Modern Chinese Medicine Group Co.,Ltd.
Copyright - Modern Chinese Medicine Group Co.,Ltd.